Sweden has become the first country to achieve the UNAIDS/WHO 90-90-90 target, research published in HIV Medicine shows. At the end of 2015, 90% of HIV cases in Sweden were diagnosed, 99.8% of patients were linked to care and 95% of patients taking antiretrovirals for ...

New MSF report exposes pharma industry failings and highlights new ways of researching and developing medicines that address public health needs Geneva, 14 September, 2016 – Governments must do more to promote the development of desperately-needed new medicines, vaccines, and diagnostics at affordable prices, urges international ...

The United Nations (U.N.) has convened high-level meetings and special sessions focused on health issues on just three occasions: to address the threats posed by HIV, noncommunicable diseases, and Ebola. On September 21, the U.N. General Assembly will convene in New York for a fourth ...

AIDS 2016: Progress and challenge summarizes major findings and discussions from the 21st International AIDS Conference in Durban, South Africa. To read the report, click here. Original Article

Current approaches to HIV prevention typically target people who are identified as, or self-identify, with being at risk. In Africa, 74% of new HIV infections are among adolescent girls aged 15–19 years, and AIDS-related illnesses are the leading cause of death among adolescent girls and ...

Clinical trial tests the effect of giving organ recipients antiviral therapy after being transplanted with kidneys that otherwise go unused PHILADELPHIA, September 13 — Patients who need a kidney transplant may have new hope, through an innovative Penn Medicine clinical trial using kidneys from deceased donors ...

APLA Health, in partnership with the California HIV/AIDS Research Program (CHRP) of the University of California, today (Sept. 12) released a new report on pre-exposure prophylaxis (PrEP) titled “Addressing PrEP Disparities among Young Gay and Bisexual Men in California.” The report includes results from a ...

Wits University researchers measured resilience in HIV patients objectively for the first time When one thinks about chronic conditions that are commonly painful, HIV doesn’t typically spring to mind. However, more than 50% of HIV-positive individuals experience a painful condition like headache, chest pain or neuropathy, ...

British Medical Journal report advises fundamental overhaul of the WHO to avoid loss of funding, warning it is at risk of repeating mistakes of the Ebola crisis Global public health experts have called for “fundamental and extensive reform” of the World Health Organisation (WHO) including major ...

PARIS, September 13: ABIVAX, an innovative biotechnology company targeting the immune system to eliminate viral disease, reported that it has completed the second key milestone of the Strategic Industrial Innovation Project CaReNa. Started in 2013, this collaborative project led by ABIVAX with the participation of CNRS ...

WOBURN, Mass., September 13–Aphios Corporation today announced that it plans to continue its research to develop a cure for HIV/AIDS using combination drugs in targeted ‘nanosomes’ nanoparticles with recent funding from the National Institute of Allergy and Infectious Diseases (NIAID), NIH. Currently, about 35 million people ...

Beerse, Belgium, 12 September 2016 – Janssen-Cilag International NV (Janssen) today announced the submission of a Marketing Authorisation Application to the European Medicines Agency (EMA), seeking approval for a new once-daily darunavir-based single tablet regimen (STR). If approved, this tablet would be the first protease ...

An effective vaccine may be necessary to eliminate hepatitis C virus (HCV) but development has been hampered by several challenges including the variability of the virus and incomplete natural immunity, according to presentations at the 5th International Symposium on Hepatitis Care in Substance Users (INHSU ...

New findings could lead to new AIDS vaccine candidates LA JOLLA, CA – September 12, 2016 – A new study from scientists at The Scripps Research Institute (TSRI) shows that “holes” in HIV’s defensive sugar shield could be important in designing an HIV vaccine. It appears that ...

For the first time, scientists know what happens to a virus’ shape when it invades a host cell, thanks to an experiment by researchers at Penn State College of Medicine and University of Pittsburgh School of Medicine. Understanding how the virus shape specifically changes could ...

EDISON, N.J., Sept. 12, 2016 — ContraVir Pharmaceuticals, Inc. (NASDAQ: CTRV), a biopharmaceutical company focused on the development and commercialization of targeted antiviral therapies, today announced that it has taken a major step forward in its pursuit of a potentially curative combination therapy for chronic ...

Announced in the lead-up to the U.N. General Assembly, $10 million joint investment supports Sustainable Development Goal 3 Washington, D.C., September 8, 2016 – The U.S. President’s Emergency Plan for AIDS Relief (PEPFAR) and biopharmaceutical company AstraZeneca today announced a $10 million (subject to the availability ...

Another ‘potential curative’ drug for people with chronic hepatitis C will be made available on the NHS. New draft guidance published today (September 9) from NICE recommends elbasvir-grazoprevir – one of the newer hepatitis C antiviral drugs that can offer patients more effective treatment. In clinical trials, ...